Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
5
Bearish filings
73
Named actors
22
Disclosed $ (bull / bear)
$22.6M + 3 of unknown size / $74.5M + 9 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-13 | 5%+ holder (13G) JPMORGAN CHASE & CO | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-09-14 | President and CEO Meeker David P | sold | $242K | SEC ↗ |
| 2026-09-14 | President and CEO Meeker David P | sold | $900K | SEC ↗ |
| 2026-09-14 | President and CEO Meeker David P | sold | $655K | SEC ↗ |
| 2026-09-14 | President and CEO Meeker David P | sold | $3.1M | SEC ↗ |
53 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-09-14 | President and CEO Meeker David P | sold | $190K | SEC ↗ |
| 2026-09-14 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) David Meeker | filed notice to sell | $5.2M | SEC ↗ |
| 2026-08-31 | Chief Financial Officer Smith Hunter C | sold | $3.0M | SEC ↗ |
| 2026-08-31 | Chief Financial Officer Smith Hunter C | sold | $1.2M | SEC ↗ |
| 2026-08-31 | Chief Financial Officer Smith Hunter C | sold | $2.4M | SEC ↗ |
| 2026-08-31 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) HUNTER SMITH | filed notice to sell | $6.7M | SEC ↗ |
| 2026-08-13 | Chief Scientific Officer Garfield Alastair | sold | $182K | SEC ↗ |
| 2026-08-13 | Chief Scientific Officer Garfield Alastair | sold | $233K | SEC ↗ |
| 2026-08-13 | Chief Scientific Officer Garfield Alastair | sold | $95K | SEC ↗ |
| 2026-08-13 | Chief Scientific Officer Garfield Alastair | sold | $402K | SEC ↗ |
| 2026-08-13 | Chief Technical Officer Shulman Joseph | sold | $608K | SEC ↗ |
| 2026-08-13 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) Jennifer Kayden Lee | filed notice to sell | $8.9M | SEC ↗ |
| 2026-08-13 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JOSEPH J SHULMAN | filed notice to sell | $597K | SEC ↗ |
| 2026-08-13 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) ALASTAIR GARFIELD | filed notice to sell | $913K | SEC ↗ |
| 2026-08-12 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) YANN MAZABRAUD | filed notice to sell | $6.4M | SEC ↗ |
| 2026-08-11 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) PAMELA CRAMER | filed notice to sell | $1.3M | SEC ↗ |
| 2026-08-10 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) PAMELA CRAMER | filed notice to sell | $407K | SEC ↗ |
| 2026-06-30 | Institution (13F) Duquesne Family Office LLC | reported a new position | $22.6M | — |
| 2026-06-24 | member of the Company’s Board of Directors Lynn Tetrault | terminated a selling plan | — | SEC ↗ |
| 2026-06-22 | Director TETRAULT LYNN A. | sold | $3.7M | SEC ↗ |